Drugmaker GlaxoSmithKline To Invest $216M In Factories, R&D In Africa
Reuters: Drugmaker GSK to invest $200 million in African factories, R&D
“Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent’s swelling urban middle classes…” (Hirschler, 3/31).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.